Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Nephrotic Syndrome × Pharmaceutical Preparations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Genitourinary 1 Gastrointestinal 1

Conditions

Nephrotic Syndrome 1 Neoplasm Metastasis 1 Kidney Diseases 1 Gastrointestinal Diseases 1 Familial Mediterranean Fever 1 Carcinoma, Hepatocellular 1 Arthritis, Rheumatoid 1 Amyloidosis 1

Interventions

Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00035334 2006-02-14

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Bellus Health Inc. - a GSK company

Phase 2/3 Completed

GastrointestinalGenitourinaryPlasma cell

Amyloidosis, Arthritis, Rheumatoid, Gastrointestinal Diseases, Kidney Diseases, Neoplasm Metastasis, Nephrotic Syndrome, Familial Mediterranean Fever

Data powered by HemOnc (CC BY 4.0) Colophon ⚡